Upstream mediators of the Fas apoptotic transduction pathway are defective in B-chronic lymphocytic leukemia

Leukemia Research

Volumn 25, Issue 11, 2001, Pages 967-980

  Roué, Gaël ^a   Lancry, Laurence ^a   Duquesne, Fabien ^a   Salaün, Véronique ^a   Troussard, Xavier ^a   Sola, Brigitte ^a  

^a CHU CÔTE DE NACRE   (France)

Author keywords

Apoptosis; Caspase; Death receptor; Fas (CD95 APO 1); Resistance; Signal transduction

Indexed keywords

CASPASE 8; CD40 ANTIGEN; DEXAMETHASONE; ETOPOSIDE; FAS ANTIBODY; FAS ANTIGEN; INTERLEUKIN 4; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; POKEWEED MITOGEN;

ADULT; AGED; ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL LINE; CELL SURFACE; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CASPASES; CELL SURVIVAL; DEXAMETHASONE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0034796299     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00063-7     Document Type: Article

References (43)

1. The Fas/Apo-1 receptor and its deadly ligand
2. The Fas death factor
3. The CD95 system and the death of a lymphocyte
4. Apoptosis by death factor
5. Transducing signals of life and death
6. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood
7. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes
8. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells
9. Fas ligation induces apoptosis of CD40-activated human B lymphocytes
10. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway
11. Tolerant B lymphocytes acquire resistance to Fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded
12. Expression and function of the Fas antigen in B chronic lymphocytic leukemia and hairy cell leukemia
13. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies
14. Fas-mediated lysis of chronic lymphocytic leukemia cells: Role of type I versus type II cytokines and autologous FasL-expressing T cells
15. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias
16. Local Fas/Apo-1 (CD95) ligand-mediated tumor cell killing in vivo
17. Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity
18. CD40 regulation of death domains containing receptors and their ligands on lymphoma B cells
19. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukemia/lymphoma cell lines
20. Expression and function of CD95 (Fas/APO-1) in leukemia-lymphoma tumour lines
21. Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions
22. Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukemia
23. Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes
24. Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukemia cells from patients with AML and CLL
25. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
26. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex (DISC)
27. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
28. Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells
29. Processing/activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells
30. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction
31. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and γ-radiation downstream from caspase-8 activation
32. Fas ligand expression in nodal non-Hodgkin's lymphoma
33. Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non Hodgkin's lymphomas and is moderately increased by CD40 ligation
34. FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis
35. Mutation analysis of the Fas and TNFR apoptotic cascade genes in hematological malignancies
36. Persistent polyclonal B lymphocytosis (PPBL) with binucleated lymphocytes: A study of 25 cases
37. Increased bcl-2/bax ratio in B-cell chronic lymphocytic leukemia is associated with a progressive pattern of disease
38. Chlorambucil resistance in B-cell chronic lymphocytic leukemia is mediated through failed Bax induction and selection of high Bcl-2 expressing subclones
39. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53
40. Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms
41. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis
42. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukemia
43. CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes